Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPN | ZTS | TAK | CTLT | NBIX |
| Company | Alpine Immune Sciences Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Catalent Inc | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NASDAQ |
| Open | 64.57 | 149.24 | 13.32 | 56.04 | 140.89 |
| High | 64.63 | 151.74 | 13.33 | 56.07 | 144.70 |
| Low | 64.56 | 148.75 | 13.21 | 55.79 | 138.01 |
| Last | 64.57 | 150.88 | 13.23 | 55.95 | 138.97 |
| Change | +0.02 | +1.32 | -0.15 | -0.08 | -1.12 |
| % Change | +0.03% | +0.88% | -1.12% | -0.14% | -0.80% |
| Volume | 1,180,100 | 3,640,400 | 924,500 | 2,031,600 | 927,900 |
| 20-Day Average Volume | 4,265,885 | 4,103,280 | 1,763,520 | 1,622,320 | 814,105 |
| Previous Close | 64.55 | 149.56 | 13.38 | 56.03 | 140.09 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 51.77 | 158.66 | 13.48 | 56.36 | 136.56 |
| 20-Day Raw Stochastic | 99.57% | 23.08% | 9.52% | 29.78% | 59.45% |
| 20-Day Relative Strength | 80.77% | 34.40% | 36.46% | 50.28% | 54.08% |
| Weighted Alpha | +307.66 | -20.05 | -20.66 | +36.62 | +39.67 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Sell | 40% Buy | 96% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 100% Sell | 40% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 40% Sell | 72% Sell | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.17% since 04/17/24 | -0.70% since 04/17/24 | +0.61% since 04/17/24 | -0.02% since 04/17/24 | +4.31% since 04/17/24 |
| Low | 64.40 on 04/19/24 | 144.80 on 04/22/24 | 13.12 on 04/18/24 | 55.42 on 04/19/24 | 130.13 on 04/19/24 |
| High | 64.70 on 04/23/24 | 153.67 on 04/18/24 | 13.41 on 04/23/24 | 56.53 on 04/18/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +64.13% since 03/22/24 | -10.67% since 03/22/24 | -8.19% since 03/22/24 | +0.29% since 03/22/24 | -1.74% since 03/22/24 |
| Low | 34.25 on 04/08/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 55.42 on 04/19/24 | 130.13 on 04/19/24 |
| High | 64.70 on 04/23/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 57.20 on 04/11/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +247.90% since 01/24/24 | -18.91% since 01/24/24 | -9.88% since 01/24/24 | +12.67% since 01/24/24 | -0.81% since 01/24/24 |
| Low | 18.86 on 01/25/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 49.52 on 01/25/24 | 128.00 on 02/07/24 |
| High | 64.70 on 04/23/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 60.20 on 02/05/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +637.94% since 10/24/23 | -9.72% since 10/24/23 | -9.26% since 10/24/23 | +31.71% since 10/24/23 | +27.20% since 10/24/23 |
| Low | 8.33 on 10/26/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 31.80 on 11/01/23 | 103.63 on 11/10/23 |
| High | 64.70 on 04/23/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 60.20 on 02/05/24 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,232,305 | 69,006,328 | 41,870,544 | 10,125,494 | 13,828,489 |
| Shares Outstanding, K | 65,546 | 457,359 | 3,164,818 | 180,974 | 99,507 |
| Annual Sales | 58,880,000 | 8,544,000,000 | 29,803,340,000 | 4,263,000,000 | 1,887,100,000 |
| Annual Net Income | -32,180,000 | 2,344,000,000 | 2,345,930,000 | -256,000,000 | 249,700,000 |
| Last Quarter Sales | 30,850,000 | 2,213,000,000 | 7,556,070,000 | 1,024,000,000 | 515,200,000 |
| Last Quarter Net Income | 5,960,000 | 525,000,000 | 718,900,000 | -206,000,000 | 147,700,000 |
| 60-Month Beta | 1.14 | 0.85 | 0.53 | 1.20 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 03/18/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | -0.24 on 02/09/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/09/24 | 06/10/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.11 | 6.86 | 0.00 | 57.89 |